Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
256-270 of 437
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Project Oncology®Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Shaji K. Kumar, MD
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Project Oncology®The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Urvi A. Shah, MD, MS
- advertisement
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Project Oncology®Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Project Oncology®Exercise in Multiple Myeloma: Balancing Benefits and Safety
Jens Hillengass, MD, PhD
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Project Oncology®Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
Project Oncology®Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges
Project Oncology®Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges
Adrienne Waks, MD
Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Project Oncology®Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Ben Park, MD, PhD
- advertisement
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Project Oncology®Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Rachelle W. Johnson, PhD
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Project Oncology®Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Constance Lehman, MD, PhD
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Project Oncology®Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches